Rise in Prevalence of Connective Tissue Disease Anticipated to Drive Global Connective Tissue Growth Factor Market: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit Connective tissue growth factor or CTGF is a revolutionary cysteine-rich, secreted peptide, which is concerned in human atherosclerosis and fibrotic disorders for instance systemic scleroderma. It is an adherent of the peptide family that contains serum-induced immediate early gene products, a putative proto-oncogene and a v-src–induced peptide. The CTGF gene family is a modular protein and is preserved throughout evolution. CTGF mRNA has been found in the mouse, chicken, human, frog, and fly. Key functions of the CTGF gene family include wound healing, embryogenesis and regulation of extracellular matrix production. Human connective tissue growth factor is undetectable in normal blood vessels but overexpressed in atherosclerotic injuries. According to study, “Global Connective Tissue Growth Factor Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use” the key companies operating in the global connective tissue growth factor market are BLR Bio LLC, ProMetic Life Sciences Inc., RXi Pharmaceuticals Corp., Hoffmann-La Roche Ltd., FibroGen Inc., Eli Lilly and Company, Abbott Laboratories, AutoImmune Inc., Bayer AG, Biogen, Pfizer, AstraZeneca, Johnson & Johnson, LUPIN, Amgen Inc. Based on product type, connective tissue growth factor market is segmented into BLR-200, OLX-201, IB-DMD, PBI-4050 and others. Based on diagnosis, market is segmented into X-ray examination, physical examination, ANA (Antinuclear Antibody Test), and others. Based on treatment, market is segmented into non-steroidal anti-inflammatory drugs (NSAIDs), antimalarial drugs, cortisone drugs or steroids, cytotoxic drugs, and others. Based on application, market is segmented into hypertrophic scars, genetic disorders, liver fibrosis, opthalmology and others. In addition, based on end-user, market is segmented into diagnostic clinics, hospital, and others. The connective tissue growth factor market is driven by increase in the research & development (R&D) efforts to find treatment or cure for connective tissue disease, followed by rise in prevalence of connective tissue disease across the globe especially in women, increase in awareness & rise in acceptance among the general population about connective tissue diseases, growth in expenditure on healthcare and high unmet medical needs of the current treatment. However, lack of funds in middle & low-income countries, inadequate R&D infrastructure and lack of a knowledgeable workforce may impact the market. Moreover, growth in support from governments across the world along with rise in funds for R&D from the private industry is a key opportunity for market. Based on geography, the North-American region holds major share in connective tissue growth factor market owing to increase in healthcare expenditure and rise in awareness among people about treatment of connective tissue disease in the region. Whereas, the European region is anticipated to exhibit substantial growth rate due to growth in improvement in reimbursement policies in healthcare over the forecast period. The Asian-Pacific region is also anticipated to exhibit substantial growth rate as a result of rise in developing healthcare technology and huge patient pool over the forecast period. In near future, it is expected that the market will be reached at rapid pace on account of rise in diagnosed and drug-treated population during the forecast period. For More Information, click on the link below:- Global Connective Tissue Growth Factor Market Research Report Related Reports:- Connective Tissue Growth Factor Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025) Global Connective Tissue Growth Factor Market Analysis 2013-2018 and Forecast 2019-2024 Contact Us:- Ken Research Ankur Gupta, Head Marketing & Communications ankur@kenresearch.com +91-9015378249 Tags: Africa Connective Tissue Growth Factor Market, Asia-Pacific Connective Tissue Growth Factor Market, BLR Bio LLC Connective Tissue Growth Factor Market, BLR-200 Connective Tissue Growth Factor Market, Europe Connective Tissue Growth Factor Market, FibroGen Inc Connective Tissue Growth Factor Market, Global Connective Tissue Growth Factor Industry, Global Connective Tissue Growth Factor Industry Research, Global Connective Tissue Growth Factor Industry Research Report, Global Connective Tissue Growth Factor Market, Global Connective Tissue Growth Factor Market Analysis, Global Connective Tissue Growth Factor Market Forecast, Global Connective Tissue Growth Factor Market Future Outlook, Global Connective Tissue Growth Factor Market Growth, Global Connective Tissue Growth Factor Market Key Players, Global Connective Tissue Growth Factor Market Research, Global Connective Tissue Growth Factor Market Research Report, Global Connective Tissue Growth Factor Market Revenue, Global Connective Tissue Growth Factor Market Scope, Global Connective Tissue Growth Factor Market Share, Global Connective Tissue Growth Factor Market Size, Global Connective Tissue Growth Factor Market Trends, Globaler Markt für Bindegewebswachstumsfaktoren, IB-DMD Connective Tissue Growth Factor Market, Marché mondial des facteurs de croissance des tissus conjonctifs, Market by Type Connective Tissue Growth Factor Market, Mercado global del factor de crecimiento del tejido conectivo, Mercato globale del fattore di crescita del tessuto connettivo, Middle East Connective Tissue Growth Factor Market, North America Connective Tissue Growth Factor Market, OLX-201 Connective Tissue Growth Factor Market, PBI-4050 Connective Tissue Growth Factor Market, Piața globală a factorilor de creștere a țesuturilor conective, ProMetic Life Sciences Inc Connective Tissue Growth Factor Market, RXi Pharmaceuticals Corp Connective Tissue Growth Factor Market, South America Connective Tissue Growth Factor Market, Thị trường nhân tố tăng trưởng mô liên kết toàn cầu, Παγκόσμια Αγορά Συντελεστή Ανάπτυξης Συνδετικού Ιστού, Глобальный рынок факторов роста соединительной ткани, سوق عامل نمو الأنسجة الضامة العالمية, 世界の結合組織成長因子市場, 全球结缔组织生长因子市场